Literature DB >> 19541708

Biomarkers of infection for the differential diagnosis of pleural effusions.

J M Porcel1, M Vives, G Cao, S Bielsa, A Ruiz-González, A Martínez-Iribarren, A Esquerda.   

Abstract

We aimed to investigate whether pleural fluid concentrations of biomarkers for bacterial infection, namely triggering receptor expressed on myeloid cells (sTREM-1), procalcitonin (PCT), lipopolysaccharide-binding protein (LBP) and C-reactive protein (CRP), might identify infectious effusions and discriminate between complicated (CPPEs) and uncomplicated parapneumonic effusions (UPPEs). Stored pleural fluid samples from 308 patients with different causes of pleural effusion were used to measure the four biomarkers. Receiver-operating characteristic analysis determined the accuracy of the new tests. Median pleural fluid levels of CRP, sTREM-1 and LBP were significantly higher in CPPE compared with those in other aetiologies. The area under the curve for distinguishing infectious (parapneumonics and tuberculosis) from noninfectious effusions was 0.87 for CRP, 0.86 for sTREM-1, 0.57 for PCT and 0.87 for LBP. Regarding the discrimination of nonpurulent CPPE versus UPPE, a multivariate analysis found that pleural fluid glucose < or =60 mg x dL(-1), LBP > or =17 microg x mL(-1) and CRP > or =80 mg x L(-1) were the best parameters. Individually, none of the new biomarkers achieved better performance characteristics than pH, glucose or lactate dehydrogenase in labelling CPPE. In conclusion, elevated pleural fluid levels of CRP, sTREM and LBP identify patients with infectious effusions, particularly those with CPPE. PCT has no value for the differential diagnosis of pleural effusions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541708     DOI: 10.1183/09031936.00197208

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  31 in total

Review 1.  Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectious diseases.

Authors:  Changlin Cao; Jingxian Gu; Jingyao Zhang
Journal:  Front Med       Date:  2017-04-19       Impact factor: 4.592

2.  Diagnostic value of soluble CD14 subtype (sCD14-ST) presepsin for the postmortem diagnosis of sepsis-related fatalities.

Authors:  Cristian Palmiere; Michele Mussap; Daniel Bardy; Francesco Cibecchini; Patrice Mangin
Journal:  Int J Legal Med       Date:  2012-12-22       Impact factor: 2.686

3.  Pleural fluid adenosine deaminase/serum C-reactive protein ratio for the differentiation of tuberculous and parapneumonic effusions with neutrophilic predominance and high adenosine deaminase levels.

Authors:  Jaehee Lee; Seung Soo Yoo; Shin Yup Lee; Seung Ick Cha; Jae Yong Park; Chang Ho Kim
Journal:  Infection       Date:  2016-08-03       Impact factor: 3.553

4.  Diagnostic value of procalcitonin in pleural effusions.

Authors:  C-Y Wang; Y-C Hsiao; J-S Jerng; C-C Ho; C-C Lai; C-J Yu; P-R Hsueh; P-C Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-13       Impact factor: 3.267

5.  Pleural infection-current diagnosis and management.

Authors:  Andrew Rosenstengel
Journal:  J Thorac Dis       Date:  2012-04-01       Impact factor: 2.895

6.  Diagnostic performance of C-reactive protein for parapneumonic pleural effusion: a meta-analysis.

Authors:  Dajiang Li; Yongchun Shen; Jiangyue Qin; Chun Wan; Ni Zeng; Lei Chen; Yue Dong
Journal:  Ann Transl Med       Date:  2019-01

7.  Tumor necrosis factor alpha and high sensitivity C-reactive protein in diagnosis of exudative pleural effusion.

Authors:  Fariba Rezaeetalab; Seyed Mohhamad Reza Parizadeh; Habibollah Esmaeely; Hadi Akbari; Farzaneh Akbari; Soheila Saberi
Journal:  J Res Med Sci       Date:  2011-11       Impact factor: 1.852

8.  Pleural fluid soluble triggering receptor expressed on myeloid cells-1 as a marker of bacterial infection: a meta-analysis.

Authors:  Hanssa Summah; Li-Li Tao; Ying-Gang Zhu; Hong-Ni Jiang; Jie-Ming Qu
Journal:  BMC Infect Dis       Date:  2011-10-20       Impact factor: 3.090

9.  Ability of procalcitonin to discriminate infection from non-infective inflammation using two pleural disease settings.

Authors:  Fiona J McCann; Stephen J Chapman; Wai Cho Yu; Nick A Maskell; Robert J O Davies; Y C Gary Lee
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

10.  Efficacy of procalcitonin and pentraxin-3 as early biomarkers for differential diagnosis of pleural effusions.

Authors:  Anita Sharma; Apurva Agrawal; Girish Sindhwani; Ashish Sharma; Sojit Tomo; Jaykaran Charan; Dharmveer Yadav; Praveen Sharma
Journal:  Pleura Peritoneum       Date:  2021-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.